Smoking adversely affects survival in acute myeloid leukemia patients

International Journal of Cancer

Volumn 130, Issue 6, 2012, Pages 1451-1458

  Varadarajan, Ramya ^a   Licht, Andrea S ^a   Hyland, Andrew J ^a   Ford, Laurie A ^a   Sait, Sheila N J ^a   Block, Annemarie W ^a   Barcos, Maurice ^a   Baer, Maria R ^a,b   Wang, Eunice S ^a   Wetzler, Meir ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

acute myeloid leukemia; outcome; smoking; treatment

Indexed keywords

CYTARABINE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856093441     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26151     Document Type: Article

References (25)

1. (CDC) CfDCaP. Centers for Disease Control and Prevention, 2008.
2. Craddock C, Nagra S, Peniket A, Brookes C, Buckley L, Nikolousis E, Duncan N, Tauro S, Yin J, Liakopoulou E, Kottaridis P, Snowden J, et al. Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica 2010; 95: 989-95.
3. Chang G, Orav EJ, McNamara T, Tong MY, Antin JH,. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer 2004; 101: 782-9. (Pubitemid 39030935)
4. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS, Koduru PR, Moore JO, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325-36. (Pubitemid 35429670)
5. Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister TA, Lo-Coco F, Willemze R, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003; 21: 4642-9. (Pubitemid 46594039)
6. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813-9. (Pubitemid 20148273)
7. Chelghoum Y, Danaila C, Belhabri A, Charrin C, Le QH, Michallet M, Fiere D, Thomas X,. Influence of cigarette smoking on the presentation and course of acute myeloid leukemia. Ann Oncol 2002; 13: 1621-7. (Pubitemid 35331461)
8. Crane MM, Strom SS, Halabi S, Berman EL, Fueger JJ, Spitz MR, Keating MJ,. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev 1996; 5: 639-44. (Pubitemid 26265159)
9. Sandler DP, Shore DL, Anderson JR, Davey FR, Arthur D, Mayer RJ, Silver RT, Weiss RB, Moore JO, Schiffer CA, et al. Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst 1993; 85: 1994-2003. (Pubitemid 24000982)
10. Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, Hagmar L,. Smoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose-response relations. Leuk Res 2001; 25: 865-72. (Pubitemid 32776577)
11. Davico L, Sacerdote C, Ciccone G, Pegoraro L, Kerim S, Ponzio G, Vineis P,. Chromosome 8, occupational exposures, smoking, and acute nonlymphocytic leukemias: a population-based study. Cancer Epidemiol Biomarkers Prev 1998; 7: 1123-5. (Pubitemid 29001669)
12. Moorman AV, Roman E, Cartwright RA, Morgan GJ,. Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups. British J Cancer 2002; 86: 60-2. (Pubitemid 34146341)
13. Mrozek K, Bloomfield CD,. Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia. Hematology / the Education Program of the American Society of Hematology. Am Soc Hematol 2006: 169-77.
14. Sakao Y, Miyamoto H, Oh S, Takahashi N, Inagaki T, Miyasaka Y, Akaboshi T, Sakuraba M,. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status. J Thorac Oncol 2008; 3: 958-62.
15. Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK,. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 2006; 106: 2428-36. (Pubitemid 43787667)
16. Abrams JA, Lee PC, Port JL, Altorki NK, Neugut AI,. Cigarette smoking and risk of lung metastasis from esophageal cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 2707-13.
17. Mai SK, Welzel G, Haegele V, Wenz F,. The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer. Radiat Oncol 2007; 2: 30.
18. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS 2004.
19. Korte JE, Hertz-Picciotto I, Schulz MR, Ball LM, Duell EJ,. The contribution of benzene to smoking-induced leukemia. Environ Health Perspect 2000; 108: 333-9. (Pubitemid 30251837)
20. Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH, Stahel R, Sabatier L, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. New Engl J Med 2006; 355: 983-91. (Pubitemid 44343542)
21. Zheng Z, Chen T, Li X, Haura E, Sharma A, Bepler G,. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. New Engl J Med 2007; 356: 800-8. (Pubitemid 46294612)
22. Yu D, Zhang X, Liu J, Yuan P, Tan W, Guo Y, Sun T, Zhao D, Yang M, Liu J, Xu B, Lin D,. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis. Clin Cancer Res 2008; 14: 2878-86.
23. Kuptsova N, Kopecky KJ, Godwin J, Anderson J, Hoque A, Willman CL, Slovak ML, Ambrosone CB,. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 2007; 109: 3936-44. (Pubitemid 46641746)
24. Varadarajan R, Cummings MK, Hyland AJ, Wang ES, Wetzler M,. Can decreasing smoking prevalence reduce leukemia mortality? Ann Hematol 2010; 89: 873-6
25. Prignot J,. Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis 1987; 70: 1-7. (Pubitemid 17218524)